Um, swordman, looked at the first 4 then stopped...nowhere on those 4 does it list Quest Clinical San Francisco, CA or Dr Jacob Lalezari as ((((((((PRINCIPAL INVESTIGATOR))))))))

Let that sink in and get back with me if you see it/him listed as such.

Pretty sure that sound like a NO... you *cannot* link which clinical trials on the clinicaltrials.gov website showing Dr. Lalezari served as Principal Investigator on clinical trials conducted for Merck, Bayer, Pfizer, and Roche.

https://www.biospace.com/article/releases/cytodyn-selects-b-quest-clinical-research-b-for-next-trial-of-hiv-aids-immune-therapy-/

Um, "chula vistia", point out and link which clinical trials on the clinicaltrials.gov website showing Dr. Lalezari served as Principal Investigator on clinical trials conducted for Merck, Bayer, Pfizer, and Roche.

WAITING

Hows about posting something a little more in tune with reality like if Dr. Lalezari served as Principal Investigator on clinical trials conducted for Merck, Bayer, Pfizer, and Roche.

https://www.biospace.com/article/releases/cytodyn-selects-b-quest-clinical-research-b-for-next-trial-of-hiv-aids-immune-therapy-/

Do SEC 8K filings come with legal disclaimers? Yes or no?

You know, like the lengthy disclaimer found in the recent conference call?

You know, shit like things said cant be necessarily considered to be truthful...

Your quote *you* emphasized in all caps--- How about we place a wager that an 8k WILL BE filed within 4 business days ???

No 8K right?

RIGHT?

Somebody hiding something?

Imagine betting the condo when this trash pumped 60%!

Nothing new there since mid 2008 but I'll bet new info will pop up in the next week or so.

Some interesting info there, Im pretty sure it explains the reason for the name change.

Uh oh!

WRONG AGAIN--- How about we place a wager that an 8k WILL BE filed within 4 business days ???

Correction: DOWN 45%

LAUGHING

DOWN 44% from 2 years ago AINT happy.

Wheres the "up 60% weeeeeeeeee!" crew?

LAUGING

Yes kgro, the FDA didnt know what the hell they were doing when they didnt grant an EUA on results of 62 patients and especially on a EUA request that was never submitted.

Welcome to koo koo land.

CytoDyn where truth wins out.--- Lets start with that...where does it show your messiah Dr. Lalezari served as Principal Investigator on clinical trials conducted for Merck, Bayer, Pfizer, and Roche?

https://www.biospace.com/article/releases/cytodyn-selects-b-quest-clinical-research-b-for-next-trial-of-hiv-aids-immune-therapy-/

Dumpers sold into the hype.

Dupes take the bait every time.

Adjusted expiration: June 1, 2024---

https://patents.google.com/patent/US7122185B2/en

Hmmm, why does IHUB have that "frown face" logo under the "Home / Boards / US OTC / Biotechs" links?

Somebody knows something.

Ahhh, its starting to sink in youve been duped eh?

It used to be bankruptcy--- Since our inception, we have been insolvent and have required debt and equity financing to maintain operations.
https://www.sec.gov/Archives/edgar/data/1175680/000155837023015718/cydy-20230531x10k.htm

there won't be a new CEO--- A guy whos been affiliated with the co since at least 2006 and the co owes $400K to.
https://www.biospace.com/article/releases/cytodyn-selects-b-quest-clinical-research-b-for-next-trial-of-hiv-aids-immune-therapy-/

Since June 1, 2021, the Company has paid Quest approximately $1.5 million for its services in conducting clinical trials of leronlimab. As of November 17, 2023, the outstanding balance owed by the Company to Quest was approximately $0.4 million.
https://www.sec.gov/Archives/edgar/data/1175680/000155837023019285/cydy-20231117x8k.htm

then they said no holds will be lifted--- Wheres that detailed 8K filing?

Pumpers yodeling for a week on the boards...now look at them.

PATHETIC

We're not arguing DATA, we're arguing if it be confirmed via clinicaltrials.gov website if Dr. Jacob Lalezari served as Principal Investigator on clinical trials conducted for Merck, Bayer, Pfizer, and Roche.

Obviously it cant be confirmed.

Is any of that info on Lalezaris resume?

I doubt the DOJ needs NP to serve up Mike and Scott.

Nps best bet would be to plead guilty and get on with it.

BWAHAHAHA! A pr wouldve been better and not created so much carnage.

But noooooooooo, the co just had to hype a conference call.

LAUGHING

Question--- Can it be confirmed via clinicaltrials.gov website Dr. Jacob Lalezari served as Principal Investigator on clinical trials conducted for Merck, Bayer, Pfizer, and Roche?

https://classic.clinicaltrials.gov/

Um, mr [see my profile pic], please show where "Dr. Lalezari served as Principal Investigator on clinical trials conducted for Merck, Bayer, Pfizer, and Roche"

Heres your quote--- I believe the new current CEO is very ethical and an extremely successful brilliant rock star of a physician/researcher, that would not waste his time or reputation on a loser.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173970829

Is/was Cytolin a winner or a loser. Where is CYDYs Cytolin now?

Whatever mr. hankey, howdy ho...--- Dr. Lalezari told a reporter from the Albuquerque Journal that he is "excited" by a "glimmer of hope" that Cytolin(R) might fulfill a "desperate need" for a salvage drug to rescue patients who are infected with multidrug resistant species of HIV. In other reports, Dr. Lalezari stated, "Cytolin(R) is the first immune therapy I've seen that has produced a significant reduction in viral burden in preliminary clinical trials. Previous attempts to develop an immune therapy for HIV disease have failed in this regard, leaving the treating physician without an immune-based drug for treating HIV/AIDS. I became interested in this project because of its potential for making a new class of drugs available for those living with AIDS."
https://www.biospace.com/article/releases/cytodyn-selects-b-quest-clinical-research-b-for-next-trial-of-hiv-aids-immune-therapy-/

So sayeth the "extremely successful brilliant rock star of a physician/researcher"

"that would not waste his time or reputation on a loser."

Wheres Cytolin now?

Wow , you are worse then I am in technology ..--- A "doctor" bad at technology?

That sums it all up. Everything makes sense now. Maybe hire an "asystent".

Why would a new CEO not accept questions in his first conference call as permanent CEO?

Wheres the "full hold" lifted 8K filing?

How many protocols were submitted to the FDA in January 2024? Were there any protocols submitted to the FDA in February 2024?

Which specific protocol on "full hold" is CYDY claiming the FDA lifted in their latest PR?

Wheres the detailed 8K filing that answers the above questions?

First Cytolin for HIV, scratch that, leronsaline for HIV, scratch that, leronsaline for covid, scratch that, leronsaline for breast cancer, scratch that, back to HIV, scratch that, leronsaline for chronic immunue activation and inflammation.

Shares Outstanding Range, Past 5 Years---
305.49M
Minimum
MAR 31 2019

979.53M
Maximum
DEC 31 2023

True or false?

Yes janice, share offerings are the kiss of death on the major exchanges.

As soon as news like that is released longs dump and shorts go berserk driving the share price down.

Good thing CYDY is on the OTC...if not, with all the numerous offerings, this junk would prolly be trading at a penny right now.

HIV chronic immune activation and inflammation study? Dont cheap drugs bought at the pharmacy like Prednisolone and Chloroquine/Hydroxychloroquine already have that market cornered?

HUH???- they won’t take live questions from shareholders in the next conf. call

No live questions, no 8K stating "full hold" has been lifted?

What the hell is going on here?

Um, mr [see my profile pic], instead of constantly snitching try reading the filings.

What sort of idiot doubles down on a co that is under SEC and DOJ investigations?

Even Fierce Biotech says ANOTHER revised protocol had been submitted AFTER the January 2024 resubmission---

Date of article Feb 29, 2024 10:20am

Yep, looks like they need any sort of carrot to dangle to dupes in the time being.

Removing pieces one by one until the FDA says yes.--- Yes kgro, I believe once again youve hit the nail squarely on the head.

Both the PR and yesterdays 424B3 filing failed to specifically mention the words "the newly proposed clinical trial protocol submitted in November 2023".

The November 2023 protocol was a no can do with the FDA---

The FDA notified the Company at the beginning of December 2023 that: (i) the FDA’s “partial hold” imposed in March 2022 had been lifted; and (ii) a new “full hold” had been applied related to the clinical trial protocol the Company submitted in November 2023 alongside the Company’s complete response to the partial clinical hold. The Company submitted a revised protocol to the FDA in January 2024, and will remain on clinical hold until the FDA clears the protocol.
https://www.sec.gov/Archives/edgar/data/1175680/000155837024001547/cydy-20240130x424b3.htm

Looking like the v.January 2024 didnt take either, somewhere a "softened up" version limped across the finish line.

Good call.

Any Sec filing relating to hold? Yup, saw that a minute or two after a 424B3 was uploaded to EDGAR yesterday.

Heres what the 12/14/2023 8K said:

Who bought the highs yesterday and today?

Fess up.

LAUGHING